GLP1R and type 2 diabetes mellitus: While GI AEs induced by GLP-1 RAs were already known from their decade-long use in the management of T2DM, the loss of LM warrants greater attention due to its potential clinical implications and the interventions required to counteract it, which remain inadequately understood.